Seegene Mexico
상단으로
Contáctenos

Noticias sobre productos Puedes verificar las últimas informaciones de productos

  • Launched Anyplex™ FluA 2 Real-time Subtyping

    Anyplex™ FluA 2 Real-time Subtyping Anyplex™ FluA 2 Real-time Subtyping enables simultaneous discrimination of influenza A virus (H1) and influenza A virus (H3) by One-step Multiplex Real-time RT-PCR. Anyplex™ FluA 2 Real-time Subtyping enables simultaneous discrimination of influenza A virus (H1) and influenza A virus (H3) by One-step Multiplex Real-time RT-PCR from nasopharyngeal swabs, nasopharyngeal aspirates, and bronchoalveolar lavage.

    Dec 01, 2009 Anyplex™ FluA 2 Real-time Subtyping

  • Launched Seeplex® Influenza A/B OneStep Typing

    Detection and identification of influenza A virus and influenza B virusWhile 2009 H1N1 Flu, seasonal influenza A and B have similar symptoms, they should be differentiated because the correct antiviral drug must be prescribed for efficacious treatment. 2009 H1N1 Flu, seasonal influenza A (H3N2), and seasonal influenza B viruses are susceptible to the neuraminidase inhibitor (Tamiflu); in contrast, seasonal influenza A (H1N1) is resistant to this drug. Also, influenza B virus is easier to catch in fall/winter and symptoms are similar to those of influenza A virus. Therefore, it is essential to differentiate between 2009 H1N1 Flu and other seasonal influenza viruses for administration of the appropriate therapy and prevention of drug resistance.

    Nov 01, 2009 Seeplex® Influenza A/B OneStep Typing

  • Launched Anyplex™ FluA/New H1N1 Real-Time Detection

    Anyplex™ FluA/New H1N1 Real-time Detection Anyplex™ FluA/New H1N1 Real-time Detection enables simultaneous detection of 2009 pandemic H1 and influenza A virus. Anyplex™ FluA/New H1N1 Real-time Detection enables simultaneous detection of 2009 pandemic H1 and influenza A virus from nasopharyngeal swabs, nasopharyngeal aspirates, and bronchoalveolar lavage in a single reaction.

    Nov 01, 2009 Anyplex™ FluA/New H1N1 Real-Time Detection

  • Obtained CE-IVD marking for Seeplex® Influenza A/B OneStep Typing

    Detection and identification of influenza A virus and influenza B virus Seegene's Seeplex® Influenza A/B OneStep Typing has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Oct 02, 2009 Seeplex® Influenza A/B OneStep Typing

  • Obtained CE-IVD marking for Seeplex®RV15 ACE Detection

    Simultaneously detecting 15 major respiratory viruses Seegene's Seeplex® RV15 ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Sep 11, 2009 Seeplex® RV15 ACE Detection

  • Obtained CE-IVD marking for Seeplex® FluA ACE Subtyping

    Seeplex® FluA ACE Subtyping Seeplex® FluA ACE Subtyping Seegene's Seeplex®  FluA ACE Subtyping has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Sep 01, 2009 Seeplex® FluA ACE subtyping

  • Obtained Medical Device License By Health Canada : Seeplex® RV7 Detection

    Simultaneously detecting major respiratory viruses Obtained Medical Device License By Health Canada : Seeplex® RV7 Detection

    Jun 24, 2009 Seeplex® RV7 Detection

  • Seeplex® RV7 Detection: Obtained Medical Device License by Health Canada

    Seeplex® RV7 Detection Simultaneously detecting major respiratory viruses

    Jun 02, 2009 Seeplex® RV7 Detection